Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Zwi Berneman practices in Edegem, Belgium. Berneman is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. They are also highly rated in 13 other conditions, according to our data. Their top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Haruo Sugiyama practices in Suita, Japan. Sugiyama is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), and Bone Marrow Transplant.
David Scheinberg is an Oncologist in New York, New York. Scheinberg has been practicing medicine for over 40 years and is rated as an Elite expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 4 other conditions, according to our data. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Leukemia, and Acute Myeloid Leukemia (AML). He is licensed to treat patients in New York.
Summary: The purpose of this study is to test whether it is safe to give Galinpepimut-S and Nivolumab together in patients with mesothelioma.
Summary: In this multicenter phase I/II trial, dendritic cells (DCs) loaded with the mesothelioma-associated tumor antigen WT1 will be used in conjunction with conventional chemotherapy for the frontline treatment of malignant pleural mesothelioma (MPM). The general objective is to provide the first-in-human experimental demonstration that the combination of platinum/pemetrexed-based chemotherapy with WT1-...